Effectiveness of Haritaki Kashayam in the Treatment of ERI Gunmam (Acid Peptic Disease)

Abstract

Acid peptic disorders develop through diverse yet interrelated pathogenic processes that lead to increased gastric acid production or impairment of mucosal protective mechanisms. Such conditions, which are commonly observed in clinical settings, contribute significantly to healthcare costs due to their persistent and chronic nature. My study aims to evaluate how effective Haritaki Kashayam is in treating Acid peptic disease (Eri Gunmam). METHOD: A descriptive case series study was undertaken among 20 patients with acid peptic disease, having a mean age of 45.65±10.19 years, at the Government Siddha Medical College and Hospital, Palayamkottai. Patients received Haritaki Kashayam (50ml twice daily) for 30 days. Clinical assessment using the Gastrointestinal Symptom Rating Scale (GSRS) was performed pre and post treatment. RESULTS: Significant improvement in GI symptoms was observed by 2^nd week and sustained through one month. Gas related discomfort markedly decreased, complemented by milder yet significant normalization of bowel habits. By day 30 (55%) of patients reported complete symptom relief, highlighting both statistical and clinical relevance. CONCLUSION: Patients with high initial GSRS scores exhibited a consistent decrease at 15- and 30-day follow-up assessments, signifying substantial symptom relief. The case series suggests that Haritaki Kashayam suspension is effective in managing acid peptic disease.